Andre Choulika

All filings by Andre Choulika on record concern Cellectis, in the capacity of chief executive. Over a trading history stretching from 3 March 2025 to 29 May 2026, the count stands at 3 filings.

Every open-market trade on record is a sale: 2 sales worth €2.6M. Outside the open market, there are 1 share grant. So far in 2026, the count stands at no purchases and 2 sales.

The newest entry dates from 4 June 2026: an open-market sale of €1.3M, in Cellectis. Typically, a trade is published a median of 6 days after it takes place. Under the Market Abuse Regulation, managers have three business days to notify their trades. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from AMF disclosures alone and does not predict where the share price will go.